Avadel Pharmaceuticals (AVDL) Return on Invested Capital: 2017-2020
Historic Return on Invested Capital for Avadel Pharmaceuticals (AVDL) over the last 3 years, with Sep 2020 value amounting to 0.02%.
- Avadel Pharmaceuticals' Return on Invested Capital rose 87.00% to 0.02% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.02%, marking a year-over-year increase of 87.00%. This contributed to the annual value of 0.01% for FY2020, which is 22.00% up from last year.
- According to the latest figures from Q3 2020, Avadel Pharmaceuticals' Return on Invested Capital is 0.02%, which was down 60.68% from 0.06% recorded in Q2 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Return on Invested Capital peaked at 6.16% during Q3 2017, and registered a low of -0.86% during Q2 2019.
- In the last 3 years, Avadel Pharmaceuticals' Return on Invested Capital had a median value of -0.24% in 2018 and averaged -0.36%.
- Per our database at Business Quant, Avadel Pharmaceuticals' Return on Invested Capital plummeted by 640bps in 2018 and then surged by 92bps in 2020.
- Avadel Pharmaceuticals' Return on Invested Capital (Quarterly) stood at 1.41% in 2017, then tumbled by 200bps to -0.59% in 2018, then skyrocketed by 35bps to -0.24% in 2019, then surged by 87bps to 0.02% in 2020.
- Its last three reported values are 0.02% in Q3 2020, 0.06% for Q2 2020, and -0.24% during Q4 2019.